US Patent Issued to AB SCIENCE, UNIVERSITE PARIS CITE, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES on Nov. 18 for "Masitinib for the treatment of sickle cell disease" (French, American Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,164, issued on Nov. 18, was assigned to AB SCIENCE (Paris), UNIVERSITE PARIS CITE (Paris), ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris) and IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES (Paris).

"Masitinib for the treatment of sickle cell disease" was invented by Alain Moussy (Paris), Jean-Pierre Kinet (Lexington, Mass.), Olivier Hermine (Paris), Thiago Trovati Maciel (Villeneuve-le-Roi, France), Slimane Allali (Meudon, France), Rachel Rignault-Bricard (Choisy-le-Roi, France) and Caroline Carvalho (Emerainville, France).

According to the abstract* released by the U.S. Patent & Trademark Office: ...